Properties (52)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
Flatiron_Health_(2018)
Genentech_(2009) Spark_Therapeutics_(2019) TIB_Molbiol_(2019) |
| gptkbp:awards |
awarded for sustainability efforts
recognized for innovation in healthcare awarded for research excellence awarded for corporate social responsibility awarded for workplace culture |
| gptkbp:CEO |
gptkb:Severin_Schwan
|
| gptkbp:clinicalTrials |
conducts numerous clinical trials globally
focus on personalized medicine focus on drug development focus on patient-centered outcomes focus on biomarker research |
| gptkbp:employees |
around 100,000
|
| gptkbp:founded |
1896
|
| gptkbp:founder |
gptkb:Fritz_Hoffmann-La_Roche
|
| gptkbp:global_presence |
operates in over 100 countries
has manufacturing sites worldwide has research facilities in multiple countries has_a_strong_presence_in_Asia has_a_strong_presence_in_Europe has_a_strong_presence_in_North_America |
| gptkbp:headquarters |
gptkb:Basel,_Switzerland
|
| https://www.w3.org/2000/01/rdf-schema#label |
Roche Holding AG
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:market |
approximately 200 billion CHF (2021)
|
| gptkbp:partnerships |
gptkb:AstraZeneca
gptkb:Gilead_Sciences Novartis Illumina Foundation Medicine |
| gptkbp:philanthropy |
gptkb:Roche_Foundation
support for cancer research support for global health initiatives support for education initiatives support for access to medicines |
| gptkbp:products |
biopharmaceuticals
diagnostics |
| gptkbp:researchAndDevelopment |
focus on oncology
focus on infectious diseases focus on neuroscience focus on immunology |
| gptkbp:revenue |
63.3 billion CHF (2020)
|
| gptkbp:stockExchange |
gptkb:SIX_Swiss_Exchange
gptkb:ROG |
| gptkbp:subsidiary |
gptkb:Genentech
|
| gptkbp:sustainability |
focus on environmental responsibility
focus on social responsibility focus on governance |